title: [Fibroblast growth factor gene expression in uterine leiomyomas].
abstract: OBJECTIVE
  The aim of the study was the evaluation of acidic and basic FGF expression, as well as collagenolitic activity in human uterine leiomyomas at various stages of tumour growth.
  
  
  METHODS
  Studies were performed on human myometrium and uterine leiomyomas of various weights (small: i.e. less than 10 g, and large: i.e. more than 100 g). The RT-PCR method was used to determine the acidic and basic FGF mRNA levels. The content of both FGF was evaluated by immunoenzymatic method (ELISA). The collagenolitic activity was detected by zymography.
  
  
  RESULTS
  A distinct increase in the expression of aFGF, the amounts of both FGFs, and collagenolitic activity was observed during the tumour growth.
  
  
  CONCLUSIONS
  Myometrium conversion into leiomyoma and an increase in its mass is accompanied by a significant increase in aFGF gene expression. The collagenolitic activity elevation favours a release of both FGF isoform from complexes with extracellular matrix components.
authors.affiliation: Zakład Biochemii Lekarskiej Uniwersytetu Medycznego w Białymstoku. ma.wolanska@interia.pl
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Wolańska
authors.forename: Emilia
authors.initials: E
authors.lastname: Bańkowska-Guszczyn
authors.forename: Stefan
authors.initials: S
authors.lastname: Jaworski
mesh_terms: D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D016220:Fibroblast Growth Factor 1 / Q000032:analysis* / Q000378:metabolism; D016222:Fibroblast Growth Factor 2 / Q000032:analysis* / Q000378:metabolism; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007889:Leiomyoma / Q000235:genetics* / Q000473:pathology; D009215:Myometrium / Q000378:metabolism* / Q000473:pathology; D012333:RNA, Messenger / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014594:Uterine Neoplasms / Q000235:genetics* / Q000473:pathology
chemical_list: D012333:RNA, Messenger; D016222:Fibroblast Growth Factor 2; D016220:Fibroblast Growth Factor 1